Latest Medivir Ser B Sek5 (MVRBF) Headlines Medivir:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Medivir Ser B Sek5 (MVRBF) Headlines

Medivir: SVR12 Results from a Phase IIa Study Evaluating Simeprevir and Daclatasvir in Hepatitis C Patients of Genotype 1 Have Been Presented
Business Wire - Tue Mar 04, 11:30AM CST
Regulatory News:

Medivir reports profit in 2013
M2 - Mon Feb 24, 6:37AM CST
Swedish medical research company Medivir AB (STO:MVIRB.ST) reported today profit after tax of SEK16m, or SEK 0.51 per share, for the year 2013, from 1 January 2013 to 31 December 2013.

Swedish Pharmaceutical Company Medivir AB Chooses Certara's D360 as Its Global Drug Discovery Platform
Business Wire - Mon Jan 27, 7:00AM CST
Certara(TM), a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that Medivir AB, a Swedish pharmaceutical company that focuses on infectious diseases including hepatitis C, has selected D360 as its global drug discovery platform. Certara's D360 is an integrated solution for the query, analysis and visualization of drug discovery and development data. Medivir will use D360 to deliver research data and analytic tools to its discovery chemists and biologists in Stockholm, Sweden, and Cambridge, UK. The information will be sourced from its existing repository of chemical structure and biological assay data.

Medivir: Interim results (SVR4) from a phase II all-oral combination study of Simeprevir and Samatasvir (IDX719) for the treatment of hepatitis C
Business Wire - Mon Jan 13, 6:22AM CST
Regulatory News:

Idenix Pharmaceuticals Reports Sustained Virologic Response Rate (SVR4) for Phase II All-Oral Combination Study of Samatasvir (IDX719), a Potent, Pan-Genotypic HCV NS5A Inhibitor, and Simeprevir
GlobeNewswire - Mon Jan 13, 6:00AM CST
Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from the Company's ongoing phase II 12-week HELIX-1 clinical trial evaluating an all-oral, direct-acting antiviral (DAA) HCV combination regimen of samatasvir (IDX719), Idenix's once-daily pan-genotypic NS5A inhibitor, and simeprevir (TMC435), a once-daily protease inhibitor jointly developed by Janssen R&D Ireland and Medivir AB, plus ribavirin. The combination regimen was well-tolerated in the study. In the treatment-naïve, non-cirrhotic, genotype 1b or 4 HCV-infected patients receiving 50 mg of samatasvir and 150 mg of simeprevir plus ribavirin, 85 percent (n=17/20) remained undetectable for HCV RNA four weeks after completing therapy (SVR4). The 50 mg dose of samatasvir is the selected dose in the ongoing 3-DAA HELIX-2 clinical trial. The HELIX-1 study results are expected to be presented at a scientific meeting in 2014.

Medivir: An all-oral phase IIa study combining Simeprevir, TMC647055 and JNJ56914845 in hepatitis C patients to be initiated
Business Wire - Thu Dec 12, 1:55AM CST
Medivir AB (STO:MVIR-B) (OMX: MVIR), announces the initiation of a phase IIa trial in chronic genotype 1 hepatitis C infected patients to evaluate the efficacy, safety and tolerability of a 12-week combination therapy of simeprevir, TMC647055 and JNJ56914845, a NS5A replication complex inhibitor.

Medivir's Simeprevir now available for Hepatitis C patients in Japan, US and Canada
M2 - Tue Dec 10, 9:57AM CST
Medivir AB (STO:MVIRB.ST), an emerging research-based pharmaceutical company focused on infectious diseases, announced today that, based on the recent approvals in Japan, Canada and US, simeprevir is now available in all three markets.

Medivir: Simeprevir is now available for Hepatitis C patients in Japan, USA and Canada
Business Wire - Tue Dec 10, 1:47AM CST
Regulatory News:

Medivir: HELIX-2, a Phase II All-Oral Combination Study of Simeprevir, TMC647055 and Samatasvir (IDX719) for the Treatment of Hepatitis C Has Been Initiated
Business Wire - Mon Dec 02, 6:29AM CST
Regulatory News:

Idenix Pharmaceuticals Announces Initiation of Enrollment in a Phase II All-Oral Combination Study of Samatasvir (IDX719), Simeprevir, and TMC647055 for the Treatment of Hepatitis C Virus (HCV) Infection
GlobeNewswire - Mon Dec 02, 6:00AM CST
Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the initiation of patient enrollment in the phase II HELIX-2 clinical trial evaluating an all-oral, direct-acting antiviral (DAA) HCV combination regimen of samatasvir, Idenix's once-daily pan-genotypic NS5A inhibitor, simeprevir, a once-daily NS3/4A protease inhibitor jointly developed by Janssen R&D Ireland and Medivir AB, and TMC647055, a once-daily NS5B non-nucleoside polymerase inhibitor boosted with low-dose ritonavir developed by Janssen.

Medivir announces approval of Simeprevir by US FDA as a new treatment for Hepatitis C
M2 - Wed Nov 27, 9:18AM CST
Medivir AB (OMX:MVIR), a research-based pharmaceutical company, announced on Saturday the approval by the US and Drug Administration (FDA) of simeprevir for the treatment of chronic hepatitis C (CHC) genotype 1 infection, in combination with peginterferon alfa and ribavirin in adults with compensated liver disease, including cirrhosis, who are treatment-naive or who have failed previous interferon therapy (pegylated or non-pegylated) with ribavirin.

Medivir AB (MVRBF) Stock Research Links

MVRBF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Villa Group’s Punta Mita Bet Adds 305 Luxury Resort Keys

Updated Category News Views 165

A 12.6-acre slice of Riviera Nayarit coastline is about to get a very expensive makeover, assuming The Villa Group can turn a handsome plan into a functioning resort without the usual development headaches. The company says it has acquired a beachfront parcel in Litibú and intends to build Villa La Valencia Punta Mita, a 305-accommodation luxury property aimed squarely...

Continue Reading
Sungrow Puts Storage Safety and Deployment on Display

Updated Category News Views 75

Fire-test footage is not usually the thing that grabs a room in Las Vegas, but Sungrow made it the centerpiece at RE+ 2026 for a reason. Energy storage has no shortage of glossy promises; what it needs is proof that equipment can handle the ugly stuff. Sungrow used the show to pitch a broader North American lineup, yet the PowerTitan 3.0 battery system and its large-scale...

Continue Reading
Albany Masonry Waterproofing Is a Quiet Value Play

Updated Category News Views 114

Winter works its mischief one soaked brick at a time. That is the unglamorous truth behind Sean Mulligan's discussion of masonry waterproofing for Albany-area homes. Brick and stone look tough enough to outlast the furniture, the siding, maybe the whole neighborhood. Yet they are porous materials, and in a region where rain, snowmelt, and sharp temperature swings keep...

Continue Reading
RAN Rebound Gains Speed, but 2027 Still Looks Flat

Updated Category News Views 7

Radio gear finally caught a pulse in the third quarter, and that matters after more than two years of contraction. Dell’Oro Group says worldwide Radio Access Network revenue rose at a mid-single-digit year-over-year rate in 3Q 2026, the market’s strongest quarterly growth in nearly five years. That is better than expected, which is a welcome change in a telecom...

Continue Reading
Elijah Craig Uses AI Toasts to Sell a Warmer Pour

Updated Category News Views 129

A Speech Prompt With a Bourbon Label Few things expose holiday nerves faster than a raised glass and a room waiting for somebody to say something memorable. Elijah Craig has decided that awkward little moment is marketing territory, rolling out its Digital Perfect Pour, Perfect Toast Generator for mobile and desktop users ahead of the holiday season. The tool asks for a...

Continue Reading
Markel's $2.5 Billion Buyback Adds Capital Flexibility

Updated Category News Views 86

A Large Checkbook, Not a Purchase Order Markel just handed management another $2.5 billion of repurchase firepower, and that deserves attention without the usual buyback cheerleading. The Board approved an increase to the existing authorization on November 18, 2026. That is a meaningful capital-allocation signal from a company built around specialty insurance,...

Continue Reading
Foresite's No. 22 Rank Signals MSSP Growth Momentum

Updated Category News Views 36

Cybersecurity rankings can be a carnival of shiny badges, but No. 22 out of 250 managed security providers is not something a serious buyer should casually brush aside. Foresite Cybersecurity landed there in MSSP Alert's 2026 survey and also made three of the program's new Prestige Top 10 lists: Best Enterprise Focused MSSP, Most Innovative MSSPs, and Fastest Growing...

Continue Reading
Cold Stone’s Holiday Menu Is a Franchisee Traffic Test

Updated Category News Views 88

Peppermint, caramel, and red velvet arrive right when dessert budgets loosen up. Cold Stone Creamery has rolled out a holiday menu running through January 5, 2027, and this is the sort of modest, practical promotion that matters more to a franchise system than the glittery language around it. Nobody should confuse two seasonal ice cream flavors with a corporate...

Continue Reading
Youdao Sets December AGM With No Vote on the Table

Updated Category News Views 74

A shareholder meeting without a vote is more temperature check than showdown, and that is exactly what Youdao has scheduled for December 17, 2026. The company will gather shareholders from 3:00 p.m. to 5:00 p.m. Beijing time at its Beijing office, but it has made one point painfully clear: no proposal will be submitted for shareholder approval. For holders of NYSE: DAO,...

Continue Reading
M.O.L.I.F.E. Brings Community Inclusion Into Public View

Updated Category News Views 23

A food pantry can reveal more about inclusion than a polished mission statement ever will. M.O.L.I.F.E., Inc. is set to be featured in an educational segment of All Access with Andy Garcia, and the useful part of this story is not the celebrity-host packaging. It is the organization’s insistence that employment, independent living, day programming, residential support,...

Continue Reading

Top 5 Most Recently Viewed Articles

Galderma Showcases Innovations in Dermatology at EADV 2024

Updated Category News Views 262

Galderma's Role at EADV 2024 At the upcoming European Academy of Dermatology and Venereology (EADV) congress, Galderma is set to highlight its important advancements in dermatology. This congress serves as a vital platform where dermatology professionals come together to exchange knowledge, explore new insights, and delve into the latest developments within the field....

Continue Reading
Exploring Growth Factors in the Scoliosis Management Sector

Updated Category News Views 131

Growth Potential in the Scoliosis Management Market Recent analyses reveal an exciting trajectory for the global scoliosis management market, projected to reach a remarkable $4.39 billion by 2034. This growth is fueled by an expected compound annual growth rate (CAGR) of 3.7% throughout the period. A significant push behind this bright future comes from the increasing...

Continue Reading
Celebrating 5 Years of Luxury Home Building with JASPER

Updated Category News Views 375

JASPER Marks Five Years of Distinctive Home Building JASPER, Nashville's foremost luxury builder, takes pride in celebrating five remarkable years of creating custom homes and inspiring renovations with a focus on precision, honesty, and a customer-centered approach. Establishing a Reputable Foundation Since its inception, JASPER has become synonymous with quality in...

Continue Reading
La Rosa Holdings Strengthens Agent Platform for Growth

Updated Category News Views 92

La Rosa Holdings Enhances Agent Platform La Rosa Holdings Corp. (NASDAQ:LRHC) has recently unveiled an upgraded version of its proprietary platform, My Agent Account, which includes a new property management module aimed at increasing operational efficiency for its agents. The My Agent Account platform has been gaining traction, evidenced by a remarkable 19%...

Continue Reading
Alkaline Water Company Partners for Expansion in New Markets

Updated Category News Views 153

Alkaline Water Company Enhances Global Presence The Alkaline Water Company, Inc. (OTC: WTER), known for its premium hydration solutions, has recently made significant strides in expanding its international footprint. In a notable move, the company has entered into a strategic international sales and distribution agreement with Global Brand and Export Development, LLC....

Continue Reading